Disclosure Of First-Time Adoption [Text Block]

Zealand Pharma - Filing #1382971

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	815,911,000 EUR	—	—	—	749,592,000 EUR	51,702,000 EUR	14,617,000 EUR	—	870,014,000 EUR	—	927,803,000 EUR	—	—	14,155,000 EUR	43,634,000 EUR	—	—	39,800,000 EUR	8,977,000 EUR	1,180,534,000 EUR	—	1,229,311,000 EUR	—	—	1,206,618,000 EUR	0 EUR	1,242,673,000 EUR	36,055,000 EUR
Comprehensive income	—	—	—	1,201,673,000 EUR	—	—	—	—	—	—	—	—	—	—	—	1,012,971,000 EUR	837,752,000 EUR	—	—	—	—	—	—	—	—	—	—	—
Profit (loss)	—	0 EUR	1,202,135,000 EUR	1,202,135,000 EUR	—	—	—	0 EUR	—	1,018,149,000 EUR	—	0 EUR	0 EUR	—	—	1,018,149,000 EUR	846,729,000 EUR	—	—	—	846,729,000 EUR	—	0 EUR	0 EUR	—	—	—	—